This year, the EHA Congress provided us with long-term follow-up of some very interesting study, including the GAIA/CLL13 ...

The European Hematology Association's annual meeting presents the latest news in hematology and its subspecialties with evidence-based approaches to diagnosis and treatment, recent clinical and ...

Geron Corporation (NASDAQ:GERN) is one of the best low priced pharma stocks to buy now. Earlier on May 28, Geron Corporation ...

The European Hematology Association's annual meeting presents the latest news in hematology and its subspecialties with evidence-based approaches to diagnosis and treatment, recent clinical and ...

Patients with (RRMM) and extramedullary disease (EMD) represent a particularly high-risk population with historically poor outcomes. In a new phase 2 analysis presented at the European Hematology ...

CTL019 consists of genetically engineered autologous T cells expressing a chimeric antigen receptor (CAR). Results from a prior single-center phase 2 study at the University of Pennsylvania showed ...

THE HAGUE, Netherlands, June 12, 2021 /PRNewswire/ -- Part 1 of the CASSIOPEIA phase-3 study compared the addition of daratumumab to bortezomib, t ...

GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients Published Jun 10, 2025 9:15am EDT ...

Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 Congress on June 12, Editas Medicine, Inc. (NASDAQ:EDIT) revealed new in vivo ...

THE HAGUE, Netherlands, July 15, 2024 /PRNewswire/ -- The European Hematology Association (EHA) has undergone a remarkable transformation over the past two years, positioning itself as a future-ready ...

THE HAGUE, Netherlands, Aug. 28, 2020 /PRNewswire/ -- European Immunotherapy Net [immunotherapy.ehaweb.org] is a new platform that brings the latest news and updates in all areas of immunotherapy ...